STAAR Surgical’s planned sale to Alcon collapsed on January 6, 2026 after shareholders rejected the revised all-cash merger ...

Staar Surgical CEO Stephen Farrell and Board of Directors Chair Elizabeth Yeu have stepped down from the company’s board, ...

These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity ...

Staar Surgical will remain independent after a bitter shareholder battle that has raged for the past several months has now ...

Alcon and STAAR Surgical terminated their definitive merger agreement. According to a press release from STAAR, preliminary ...

STAAR Surgical said on Tuesday it plans to terminate its merger agreement with Swiss eyecare giant Alcon after failing to ...

An activist investor has reshaped the board, securing the departures of STAAR’s CEO and chair.

STAAR Surgical (STAA) said that Neal C. Bradsher and Richard T. LeBuhn of Broadwood Partners and Christopher Wang of Yunqi ...

STAAR Surgical has announced that it will terminate the proposed acquisition by Alcon based on preliminary estimates by STAAR ...

The implantable lens maker said it would remain a stand-alone company after its shareholders turned down Alcon’s $1.6 billion offer.

STAAR Surgical said shareholders rejected its merger with Alcon, ending the $1.6 billion deal. The eye care company will remain independent and focus on growth and wider use of its EVO lens.

STAAR Surgical is terminating its agreement to merge with Swiss eyecare specialist Alcon in a $1.6bn deal, ending a ...